| Ημερομηνία | barcode | code | περιεχομενο | τιμή παραγωγός | χονδρική | λιανική |
|---|---|---|---|---|---|---|
| 05/2018 | 2802012201011 | 201220101 | POTASSIUM CHLORIDE 0.2% IN DEXTROSE 5%/ΒΙΟΣΕΡ INJ.SO.INF (0.2%+5%)W/V BTX1 BOTTLE X 1000 ML (σε συσκευασία των 10 BOTTLES) | 1.21 | 1.27 | 1.75 |
| 05/2018 | 2801919801034 | 191980103 | POTASSIUM CHLORIDE IN DEXTROSE INJ./FRESENIUS INJ.SO.INF 5%+0,2% BOTTLEX1000ML | 01.05 | 1.10 | 1.51 |
| 05/2018 | 2803010101020 | 301010102 | POTASSIUM CHLORIDE/ADIPHARM C/S.SOL.IN 10% (W/V) BTx50 PL. AMPx10 ML | 0.52 | 0.55 | 0.77 |
| 05/2018 | 2802776101022 | 277610102 | POTASSIUM CHLORIDE 15%/NORIDEM C/S.SOL.IN 150MG/ML BTx20 AMP x 10 ML | 0.57 | 0.60 | 0.83 |
For use as an electrolyte replenisher and in the treatment of hypokalemia.
Supplemental potassium in the form of high potassium food or potassium chloride may be able to restore normal potassium levels.
The administration of oral potassium salts to persons with normal excretory mechanisms for potassium rarely causes serious hyperkalemia. However, if excretory mechanisms are impaired, of if potassium is administered too rapidly intravenously, potentially fatal hyperkalemia can result. It is important to recognize that hyperkalemia is usually asymptomatic and may be manifested only by an increased serum potassium concentration (6.5-8.0 mEq/L) and characteristic electrocardiographic changes (peaking of T-waves, loss of P-wave, depression of S-T segment, and prolongation of the QT interval). Late manifestations include muscle paralysis and cardiovascular collapse from cardiac arrest (9-12 mEq/L).
Potassium is a normal dietary constituent and under steady-state conditions the amount of potassium absorbed from the gastrointestinal tract is equal to the amount excreted in the urine.
Potassium is a normal dietary constituent and, under steady-state conditions, the amount of potassium absorbed from the gastrointestinal tract is equal to the amount excreted in the urine. Potassium depletion will occur whenever the rate of potassium loss through renal excretion and/or loss from the gastrointestinal tract exceeds the rate of potassium intake.